Medical Research News
Focus on the latest clinical studies, reports, findings, programs and standards covering a wide spectrum of medical and health issues. This section highlights research into human populations and includes information about research facilities, funding, resources and public policy.
Immundiagnostik and Preventis GmbH Go Beyond the Lab at the AACC’s Annual Scientific Meeting and Clinical Lab Expo
Immundiagnostik and Preventis GmbH will exhibit together at the upcoming AACC Clinical Lab Expo July 26-28 in Chicago, IL in support of improved patient care. - July 11, 2022 - Immundiagnostik, Inc.
Team Arnav Foundation to Hold 3rd Annual Event
Public announcement telling folks to participate in a local event whose proceeds help eradicate pediatric osteosarcoma. - July 09, 2022 - Team Arnav Foundation
George Sotos, MD Named Practice President of Maryland Oncology Hematology
Maryland Oncology Hematology (MOH), the largest independent oncology practice in Maryland and a member of The US Oncology Network, has elected George Sotos, MD as the new practice President. Dr. Sotos succeeds Dr. Joseph Haggerty as of June 1 and will serve a three-year term. Dr. Sotos practices... - July 06, 2022 - Maryland Oncology Hematology
Kalimullah Quadri, MD Joins New York Cancer & Blood Specialists
New York Cancer & Blood Specialists (NYCBS), one of the leading oncology practices in the Nation, is pleased to announce that Kalimullah Quadri, MD has joined the team of oncologists-hematologists. He will be practicing at 447 Atlantic Avenue, Brooklyn, NY 11217, and 121 Dekalb Avenue,... - July 06, 2022 - New York Cancer & Blood Specialists
Aleksander Vayntraub, MD Joins New York Cancer & Blood Specialists
New York Cancer & Blood Specialists (NYCBS), one of the leading oncology practices in the nation, is pleased to announce that board-certified radiation oncologist Aleksander Vayntraub, MD, has joined the team of radiation oncologists. He will be practicing at NYCBS sites in Setauket, Patchogue,... - July 06, 2022 - New York Cancer & Blood Specialists
TrialX Launches a DEI Toolkit Within iConnect Platform to Tackle Diversity Challenges in Clinical Trial Recruitment
To overcome barriers to participation of diverse populations in clinical trials, TrialX launches a toolkit for sponsors and sites to create an end to end multilingual experience for patients. - June 21, 2022 - TrialX
Lead Medical is Honored in 24th Annual Digital Health Awards® Spring 2022 Session
Lead Medical’s Cath Lab Reporting System was selected as a winner at the 24th annual Digital Health Awards® program which recognizes the world’s best digital health resources. Receiving a Merit Award for Connected Digital Health, Lead Medical became the only Chinese digital health company recognized in the list of winners for the Spring 2022 session. - June 18, 2022 - Lead Medical
PharmStars Announces “Innovations in Real-World Evidence” Theme for Fall 2022 Accelerator
PharmStars, the pharma-focused accelerator for digital health startups, announces it is now accepting applications for its Fall 2022 cohort with the theme, “Innovations in Real-World Evidence.” - June 15, 2022 - PharmStars
PharmStars Announces Showcase Pitch Event for Spring 2022 Cohort
PharmStars, the pharma-focused accelerator for digital health startups, announces the start of its Showcase Event on June 8, 2022. The digital health startups that participated in the 10-week accelerator program will make formal presentations to, and answer questions from, the pharma members of PharmStars. All of PharmStars’ seven members are participating in the Showcase Event. - June 08, 2022 - PharmStars
Isaac Health Launches Affordable, Convenient Specialist Memory Clinic Services at Home
Isaac Health is a national provider of dementia care via a virtual platform from the safety of your home. They diagnose, treat, manage, and coordinate care for you in collaboration with your physician, loved ones, and/or senior living community - June 04, 2022 - Isaac Health
Eledon Announces Phase 2a Trial Results of Tegoprubart (AT-1501) – a Drug Invented at ALS TDI
Eledon Pharmaceuticals announced topline results from their Phase 2 trial of tegoprubart (formerly AT1501), a drug invented and developed at the ALS Therapy Development Institute (ALS TDI). The Phase 2a trial in ALS was a 12-week, open label, dose escalating, safety, and biomarker study. The... - May 31, 2022 - ALS Therapy Development Institute
Paradigm Immunotherapeutics to Present at LABEST 2022 Incubator Showcase
Dr. Neil Bodie, CEO of Paradigm, will discuss Paradigm’s groundbreaking biological, virtual mask in his presentation, “A Breakthrough in SARS CoV-2/COVID Prophylactics.” Dr. Neil Bodie, CEO of Paradigm Immunotherapeutics (“Paradigm”), will present at the Los Angeles... - May 25, 2022 - Paradigm Immunotherapeutics
ALS Therapy Development Institute Scientists to Present Posters Sharing Research Advancements at the ALS Drug Development Summit
The ALS TDI scientists will be showcasing significant advancements in ALS research through multiple poster presentations. These posters will cover pre-clinical research exploring potential new therapeutic drug-like molecules and targets for ALS, as well as translational research analyzing patient data to identify new ALS biomarkers, drug targets, and patient populations. - May 25, 2022 - ALS Therapy Development Institute
ASAcampus Involved Once Again in an Experiment That Will Take Place on the International Space Station
The experiment, selected by the European Space Agency in the ESA-ILSRA2014 call and with the support of the Italian Space Agency (C-ASI N. 2018-14-U.0-Suture in Space), aims to study the process of surgical wound healing in space. - May 22, 2022 - ASA srl
LifeBiotic's Botanical Formula Shows Significant Destruction of Multiple GI Cancer Cells
In a new cell model study, the patented LCS101 formula eliminated up to 90% of cancer cells within 72 hours. - May 19, 2022 - Lifebiotic
Vesalio Announces the Completion of Enrollment in Its FDA IDE Clinical Study for Acute Ischemic Stroke
Vesalio announces the completion of enrollment in its FDA IDE clinical study for acute ischemic stroke. - May 11, 2022 - Vesalio
The ALS TDI Discovery Biology Suite Dedicated in Honor of Liz Bodine to Speed Drug Development in ALS
The ALS Therapy Development Institute (ALS TDI) and Augie’s Quest to Cure ALS are proud to honor the commitment of Liz Bodine to facilitate more effective ALS drug discovery at ALS TDI, the world’s most comprehensive drug discovery lab dedicated solely to ALS. - May 04, 2022 - ALS Therapy Development Institute
Cyclists Support ALS Research with 3-Day, 270-Mile Ride from Boston to Greenwich in Tri-State Trek
Hundreds of riders to join the ride to end ALS this June and raise funds for cutting-edge ALS research. ALS TDI has received a $100,000 match for all donations made to the Tri-State Trek through the month of May. - May 03, 2022 - ALS Therapy Development Institute
Dr. Salar Khan is Due to be Featured on the Front Cover of 2022 Top 100 Doctors Magazine's Q1 Edition
Dr. Salar Khan is named "Doctor & Leader of the Year" and is being honored with Top 100 Doctors' "Lifetime Achievement Award in Medicine & Leadership" for the year 2022. - April 27, 2022 - Top100 Registry Inc.
PDD and Tri-Star Design Announce Healthcare Market Partnership
PDD and Tri-Star Design announced, today, a new partnership that will accelerate innovation, design and development for a rapidly expanding digital healthcare market. Founded in 1991, Tri-Star Design collaborates with innovative high-tech companies to provide turn-key design and development... - April 11, 2022 - Tri-Star Design, Inc.
Best Medical Website to be Named by Web Marketing Association in 26th Annual WebAward Competition
The Web Marketing Association will name the best medical websites in the world as part of their 26th annual international WebAward Competition for Web site development. Medial Websites can be entered into consideration for the 2022 Best Medical Website and other medical-related WebAwards at www.webaward.org. - April 10, 2022 - Web Marketing Association
EndoSoft® Announces ISO 13485:2016 Certification
EndoSoft, a Leading Health IT Company, announced today that they received ISO 13485:2016 Quality Management System Certification for the design, development, integration, and support of Electronic Health Record (EHR) and Artificial Intelligence (AI) software products (Registered by SRI Quality... - April 01, 2022 - EndoSoft
The Medical Center of Aurora Recognized by the American College of Cardiology in the “Best Hospitals” Issue of U.S. News & World Report
The Medical Center of Aurora has been recognized by the American College of Cardiology in the “Best Hospitals” issue of U.S. News & World Report as the top ranked hospital in Colorado for providing outstanding care to heart patients. - March 29, 2022 - The Medical Center of Aurora
Experienced Hematologist and Medical Oncologist Harminder Sethi, MD joins Maryland Oncology Hematology
Dr. Sethi has over 18 years of experience, specializing in targeted and biological therapy. - March 29, 2022 - Maryland Oncology Hematology
David Zagzag, MD, Ph.D Celebrated as an Honored Member for 2022 by Strathmore's Who's Who Worldwide Publication
David Zagzag, MD, Ph.D. of Rego Park, New York has been recognized as an Honored Member for 2022 by Strathmore’s Who’s Who Worldwide Edition for his outstanding contributions and high level of success in the medical field. About David Zagzag, MD, Ph.D. David Zagzag, MD, Ph.D. is a... - March 29, 2022 - Strathmore Worldwide
Med Bed Technology Products Now Beginning to be Released to Public
What is a "med bed" and when are med beds coming? Although the release of med beds mentioned in various underground programs have not been released yet there are many med bed light frequency technologies and technology products now providing various health benefits to users. Hospital Direct Medical looks at Tesla Plasma Chambers, Terahertz Wands, Tesla Ozone Ray's, Anti Aging Bed Covers and other products are now available. - March 28, 2022 - Hospital Direct Medical Equipment Inc.
C.A.M.P Brings New Hope to Alzheimer’s and Dementia Patients
A recent study conducted of CAMP (Cognitive Assessment & Memory Program), a neuro-digital health platform, has yielded exciting results for those suffering from mild to moderate cognitive impairment. - March 17, 2022 - campformemory.com
PurerVita Ltd. Launches UK First Revolutionary Supplements for Pregnancy and Postpartum Recovery
Launch of PurerMama, A positive impact nutritional and wellness brand by doctors at The Baby Show, Excel London. - March 12, 2022 - PurerVita UK Limited
Healthy Hope - Documentary Film Premieres at the Amelia Island Film Festival
The documentary "Healthy Hope" will makes its premiere Saturday, February 25, 2022 at the Amelia Island Film Festival in Florida. The film is about the research being done on the cancer fighting & curative properties of the Muscadine Grape. Doctors from NC State, Wake Forest University, Howard University, Morgan State University, and Johns Hopkins University talk about the results they have seen in their studies. - February 25, 2022 - CLINNEAM LLC
FOXG1 Research Foundation Hosts Napa Valley Charity Golf Tournament to Accelerate Research for Pediatric Neurological Disorder
Scientists believe FOXG1 may hold the key to unlocking brain disorders affecting millions, including autism, Alzheimer’s, brain tumors and more. - February 23, 2022 - FOXG1 Research Foundation
2022 Women in Oncology Awards
The Women in Oncology Awards are presented annually to outstanding women who have made remarkable contributions to the lives of those fighting cancer. The winners of the 2022 Women in Oncology Awards are Karen Kelly, MD, FASCO, Elizabeth A. Mittendorf, MD, PhD, and Rachna T. Shroff, MD, MS. - February 23, 2022 - Cancer Expert Now, Inc.
FOXG1 Research Foundation’s Hourinaz Behesti PhD to Present at BIO CEO & Investor Conference 2022
The FOXG1 Research Foundation, the rare disease patient organization that is driving the science to find treatments for FOXG1 syndrome, will be presenting at the BIO CEO & Conference on February 14 to discuss Tapping into Therapeutic Development for Rare CNS Disorders. Dir. of Science, Hourinaz Behesti will discuss why FOXG1 is a viable target for biotech investment, and the suite of assets that the FRF has developed and characterized to help accelerate drug development. - February 09, 2022 - FOXG1 Research Foundation
Nagwa Saleh, MD Joins New York Cancer & Blood Specialists
New York Cancer & Blood Specialists (NYCBS), one of the Nation’s leading oncology practices, is pleased to announce the addition of board-certified radiation oncologist Dr. Nagwa Saleh. She will practice at 365 E Main Street, Patchogue, NY 11772. “Dr. Saleh brings extraordinary... - February 01, 2022 - New York Cancer & Blood Specialists
MacroArray Diagnostics GmbH (MADx) Partners with ALPCO to Offer a Fully Automated Sample-to-Answer Multiplex Allergy Test Solution to the North American Market
ALPCO (Salem, NH), a leading US producer of novel immunoassay testing platforms, recently announced an exclusive distribution partnership with MacroArray Diagnostics GmbH (Vienna, Austria). Together, they offer a comprehensive line of testing solutions for allergies (IgE-based) and food intolerances (IgG-based), from test material to proprietary hardware and software to process and analyze samples. - February 01, 2022 - ALPCO
Announcing the 2022 Kumar Patel Prize in Laser Surgery Recipients Dr. Robert M. Pick, Dr. L. Miguel Carreira, and Dr. Pedro Azevedo
The American Laser Study Club (ALSC) awards the 2022 Kumar Patel Prize in Laser Surgery to the following highly accomplished and respected laser surgery providers, educators, pioneers, and researchers: Robert M. Pick, DDS, MS, for pioneering contributions to CO2 laser dental applications and... - January 29, 2022 - American Laser Study Club
Terrain Health Pioneers Long Hauler Treatment with Wider Applications to Long Term Diseases
Leveraging cutting edge research, Dr. Robin Rose of Terrain Health can better predict, diagnose and optimize treatment for patients experiencing persistent symptoms of long haul COVID along with other chronic diseases, such as Lyme’s disease and Chronic Fatigue Syndrome. Dr. Rose is working to build upon the latest information, incorporating the role of the gut microbiome and its interconnectivity with the body’s overall immune health. - January 27, 2022 - Terrain Health Inc.
Verna J. Kirkness Foundation Announces Their New Executive Director
The Verna J. Kirkness Education Foundation is pleased to announce Amber Boyd as the new Executive Director for the foundation. Amber holds a Bachelor of Science Degree in Psychology, a Human Resource Management Certificate and a Creative Writing Certificate from the University of Calgary. She is a... - January 25, 2022 - Verna J. Kirkness Foundation
Innovation and Value Initiative Elects New Board Members
New Directors Reflect Diverse Sectors of Healthcare. - January 18, 2022 - Innovation and Value Initiative
Brianna Marie Foundation - Offering Hope to Unborn Babies and Their Families
Are you aware that you can operate on babies prior to birth and give unborn babies that have been diagnosed with a negative fetal diagnosis a chance to live a normal, healthy lifestyle. Parents Aran and Patrick Hissam started a non-profit called the Brianna Marie Foundation in honor of their daughter that passed away ten years ago from a fetal illness known as fetal hydrops. To date, the organization has raised over $550K and funds research around the world. - January 13, 2022 - Brianna Marie Foundation
VoCare Names MobilDrTech US Distribution Partner for Vitals360® Remote Monitoring Device
MobilDrTech, Inc. is proud to announce its’ selection by VoCare as a solutions partner to market and distribute their Vitals360® device for Remote Patient Monitoring and Chronic Care Management (RPM/CCM). The product, with 4G LTE cellular, Wi-Fi and Bluetooth capabilities on a pocket-sized device, is available immediately from MobilDrTech for medical providers, telemedicine equipment and service providers, hospitals, health systems, home health agencies and third-party payers. - January 13, 2022 - MobilDrTech, Inc.
LifeTein Awarded the Fastest Peptide Synthesis Service in 2021
LifeTein was awarded the fastest peptide synthesis service in 2021 by New world Report, thanks to their speedy custom protein, antibody, and chemical services for biotech, pharma, academia, government customers, and diagnostics. Their services reach across the entire United States and more than 30 other nations. LifeTein provides the fastest turnaround time and most reliable quality in the industry, using their proprietary microwave-assisted heating technology for peptide synthesis. - January 07, 2022 - LifeTein
Shreya P. Goyal, MD Joins New York Cancer & Blood Specialists in Brooklyn
New York Cancer & Blood Specialists (NYCBS), one of the leading oncology practices in the Nation, is thrilled to announce the addition of hematologist-oncologist Shreya P. Goyal, MD. She will be practicing at 447 Atlantic Ave., Brooklyn, NY 11217, and the Brooklyn Cancer Center at 121 Dekalb... - January 04, 2022 - New York Cancer & Blood Specialists
Dr. Minh-Phuong Huynh-Le Joins New York Cancer & Blood Specialists in Brooklyn
New York Cancer & Blood Specialists (NYCBS), one of the leading oncology practices in the Nation, is thrilled to announce the addition of board-certified radiation oncologist Dr. Minh-Phuong Huynh-Le. She will be practicing at 121 DeKalb Ave, Brooklyn, NY 11201. “We are pleased to... - January 04, 2022 - New York Cancer & Blood Specialists
Viron Announces New CFO Hire
Viron Therapeutics Holdings, Inc., a Boston biotech company, is pleased to announce the appointment of Jodie Fisher as its Executive Vice President and Chief Financial Officer (CFO). Fisher will lead the Company’s finance organization and drive investor relations. Fisher’s entry into... - December 29, 2021 - Viron Therapeutics Holdings, Inc.
Vesalio Initiates Clinical Study Evaluating Innovative Thrombectomy Technique for Patients with STEMI
Vesalio Initiates Clinical Study Evaluating Innovative Thrombectomy Technique for Patients with STEMI. - December 23, 2021 - Vesalio
IVI Opens Public Comment Period for Major Depressive Disorder Model Draft Protocol
Nonprofit Seeks Input Into Data Sources and Technical Specifications to Guide Model Development; Will Hold December 15 Webinar to Overview Protocol and Public Comment Process - December 14, 2021 - Innovation and Value Initiative
PharmStars Announces 2021 Accelerator Graduates
12 digital health startups have successfully completed PharmStars’ inaugural 10-week pharma-focused accelerator program. - December 08, 2021 - PharmStars
First Medical Food for the Dietary Management of Polycystic Kidney Disease Launched
Scientific breakthroughs for kidney disease lead to the launch of the first-ever medical food for the daily dietary management of Polycystic Kidney Disease (PKD). - December 06, 2021 - Santa Barbara Nutrients
Tarun Wasil, MD Joins New York Cancer & Blood Specialists in Lake Success
New York Cancer & Blood Specialists (NYCBS), one of the Nation’s leading oncology practices, is pleased to announce the addition of board-certified hematologist-oncologist Tarun Wasil, MD. He will be practicing at 1 Delaware Drive, Lake Success, NY... - December 01, 2021 - New York Cancer & Blood Specialists
Pine Biotech to Support Data Science and Bioinformatics for the National Association of IDeA Principal Investigators
Pine Biotech has announced a contract to support the National Association of IDeA Principal Investigators (NAIPI), a membership-supported non-profit organization (501.3 C) that brings together NIH-funded principal investigators that receive NIGMS IDeA funding. The organization holds regular events and advocates on behalf of it’s members, showcasing the value of funding and identifying best strategies to a address the funding gaps that exist in 23 states and Puerto Rico, termed the "IDeA states." - December 01, 2021 - Pine Biotech